Macrophages, Inflammation, and Tumor Suppressors: ARF, a New Player in the Game
Open Access
- 18 December 2012
- journal article
- review article
- Published by Hindawi Limited in Mediators of Inflammation
- Vol. 2012, 1-11
- https://doi.org/10.1155/2012/568783
Abstract
The interaction between tumor progression and innate immune system has been well established in the last years. Indeed, several lines of clinical evidence indicate that immune cells such as tumor-associated macrophages (TAMs) interact with tumor cells, favoring growth, angiogenesis, and metastasis of a variety of cancers. In most tumors, TAMs show properties of an alternative polarization phenotype (M2) characterized by the expression of a series of chemokines, cytokines, and proteases that promote immunosuppression, tumor proliferation, and spreading of the cancer cells. Tumor suppressor genes have been traditionally linked to the regulation of cancer progression; however, a growing body of evidence indicates that these genes also play essential roles in the regulation of innate immunity pathways through molecular mechanisms that are still poorly understood. In this paper, we provide an overview of the immunobiology of TAMs as well as what is known about tumor suppressors in the context of immune responses. Recent advances regarding the role of the tumor suppressor ARF as a regulator of inflammation and macrophage polarization are also reviewed.Keywords
This publication has 135 references indexed in Scilit:
- Alternatively activated macrophages in infection and autoimmunityJournal of Autoimmunity, 2009
- Mucins in cancer: function, prognosis and therapyNature Reviews Cancer, 2009
- Tumor-associated macrophages and the related myeloid-derived suppressor cells as a paradigm of the diversity of macrophage activationHuman Immunology, 2009
- Murine ovarian cancer vascular leukocytes require arginase-1 activity for T cell suppressionMolecular Immunology, 2008
- Toll-like receptors and innate immunityJournal of Molecular Medicine, 2006
- Clodronate-liposome-mediated depletion of tumour-associated macrophages: a new and highly effective antiangiogenic therapy approachBritish Journal of Cancer, 2006
- Tumour-educated macrophages promote tumour progression and metastasisNature Reviews Cancer, 2004
- Alternative activation of macrophagesNature Reviews Immunology, 2003
- The role of tumour‐associated macrophages in tumour progression: implications for new anticancer therapiesThe Journal of Pathology, 2002
- Mdm2 promotes the rapid degradation of p53Nature, 1997